Dual PD-1 and CTLA-4 Checkpoint Blockade Using Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer: An Open-Label Phase II Study.
Saved in:
| Title: | Dual PD-1 and CTLA-4 Checkpoint Blockade Using Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer: An Open-Label Phase II Study. |
|---|---|
| Authors: | O'Malley DM; Division of Gynecologic Oncology, The Ohio State University/James Comprehensive Cancer Center, Columbus, OH., Neffa M; CI of Healthcare Regional Clinical Specialized Dispensary of the Radiation Protection, Kharvik, Ukraine., Monk BJ; Division of Gynecologic Oncology, Arizona Oncology (US Oncology Network), University of Arizona, Creighton University, Phoenix, AZ., Melkadze T; Research Institute of Clinical Medicine, Tbilisi, Georgia., Huang M; Division of Gynecologic Oncology, University of Miami School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL., Kryzhanivska A; Regional Clinical Oncology Center, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine., Bulat I; ARENSIA Exploratory Medicine Unit, Institute of Oncology, Chisinau, Moldova., Meniawy TM; Linear Clinical Research, Nedlands, Australia., Bagameri A; Országos Onkológiai Intézet, Budapest, Hungary., Wang EW; Medical Oncology and Therapeutic Research, City of Hope Comprehensive Cancer Center, Duarte, CA., Doger de Speville Uribe B; START Madrid FJD, Madrid, Spain., Hegg R; Clínica de Pesquisa e Centro de Estudos em Oncologia Ginecológica e Mamária, Sao Paulo, Brazil., Ortuzar Feliu W; Agenus Inc, Waltham, MA., Ancukiewicz M; Agenus Inc, Waltham, MA., Lugowska I; Maria Sklodowska-Curie National Research Unit of Oncology, Warsaw, Poland. |
| Source: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Mar 01; Vol. 40 (7), pp. 762-771. Date of Electronic Publication: 2021 Dec 21. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34932394 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Dual PD-1 and CTLA-4 Checkpoint Blockade Using Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer: An Open-Label Phase II Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22O'Malley+DM%22">O'Malley DM</searchLink>; Division of Gynecologic Oncology, The Ohio State University/James Comprehensive Cancer Center, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Neffa+M%22">Neffa M</searchLink>; CI of Healthcare Regional Clinical Specialized Dispensary of the Radiation Protection, Kharvik, Ukraine.<br /><searchLink fieldCode="AU" term="%22Monk+BJ%22">Monk BJ</searchLink>; Division of Gynecologic Oncology, Arizona Oncology (US Oncology Network), University of Arizona, Creighton University, Phoenix, AZ.<br /><searchLink fieldCode="AU" term="%22Melkadze+T%22">Melkadze T</searchLink>; Research Institute of Clinical Medicine, Tbilisi, Georgia.<br /><searchLink fieldCode="AU" term="%22Huang+M%22">Huang M</searchLink>; Division of Gynecologic Oncology, University of Miami School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL.<br /><searchLink fieldCode="AU" term="%22Kryzhanivska+A%22">Kryzhanivska A</searchLink>; Regional Clinical Oncology Center, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine.<br /><searchLink fieldCode="AU" term="%22Bulat+I%22">Bulat I</searchLink>; ARENSIA Exploratory Medicine Unit, Institute of Oncology, Chisinau, Moldova.<br /><searchLink fieldCode="AU" term="%22Meniawy+TM%22">Meniawy TM</searchLink>; Linear Clinical Research, Nedlands, Australia.<br /><searchLink fieldCode="AU" term="%22Bagameri+A%22">Bagameri A</searchLink>; Országos Onkológiai Intézet, Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Wang+EW%22">Wang EW</searchLink>; Medical Oncology and Therapeutic Research, City of Hope Comprehensive Cancer Center, Duarte, CA.<br /><searchLink fieldCode="AU" term="%22Doger+de+Speville+Uribe+B%22">Doger de Speville Uribe B</searchLink>; START Madrid FJD, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Hegg+R%22">Hegg R</searchLink>; Clínica de Pesquisa e Centro de Estudos em Oncologia Ginecológica e Mamária, Sao Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Ortuzar+Feliu+W%22">Ortuzar Feliu W</searchLink>; Agenus Inc, Waltham, MA.<br /><searchLink fieldCode="AU" term="%22Ancukiewicz+M%22">Ancukiewicz M</searchLink>; Agenus Inc, Waltham, MA.<br /><searchLink fieldCode="AU" term="%22Lugowska+I%22">Lugowska I</searchLink>; Maria Sklodowska-Curie National Research Unit of Oncology, Warsaw, Poland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2022 Mar 01; Vol. 40 (7), pp. 762-771. <i>Date of Electronic Publication: </i>2021 Dec 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34932394 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1200/JCO.21.02067 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 762 Titles: – TitleFull: Dual PD-1 and CTLA-4 Checkpoint Blockade Using Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer: An Open-Label Phase II Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: O'Malley DM – PersonEntity: Name: NameFull: Neffa M – PersonEntity: Name: NameFull: Monk BJ – PersonEntity: Name: NameFull: Melkadze T – PersonEntity: Name: NameFull: Huang M – PersonEntity: Name: NameFull: Kryzhanivska A – PersonEntity: Name: NameFull: Bulat I – PersonEntity: Name: NameFull: Meniawy TM – PersonEntity: Name: NameFull: Bagameri A – PersonEntity: Name: NameFull: Wang EW – PersonEntity: Name: NameFull: Doger de Speville Uribe B – PersonEntity: Name: NameFull: Hegg R – PersonEntity: Name: NameFull: Ortuzar Feliu W – PersonEntity: Name: NameFull: Ancukiewicz M – PersonEntity: Name: NameFull: Lugowska I IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2022 Mar 01 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1527-7755 Numbering: – Type: volume Value: 40 – Type: issue Value: 7 Titles: – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology Type: main |
| ResultId | 1 |